Social Media Ideas for Abbv:ca

Abaxx Technologies Inc. 2026 Q2 - Results - Earnings Call Presentation

HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.

A recent analyst lays out a concrete bull case, but it is not the only path to higher prices for AbbVie.

Abbott Laboratories (ABT) Dividend Stock Analysis

Linked here is a detailed quantitative analysis of Abbott Laboratories (ABT). Below are some highlights from the above linked analysis: Company Description: This diversified healt...

Should You Buy AbbVie Stock Before Oct. 30?

The healthcare company will release its third-quarter numbers later this month.

AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie generates $17.8 billion in annual free cash flow but faces patent cliffs, while Vertex boasts a 33% net margin with concentrated cystic fibrosis exposure.

A & W Food Services of Canada Inc. (AW:CA) Q3 2026 Earnings Call Transcript

Pfizer: Growth Portfolio And Cost Cuts Support A Buy Through The LOE Trough

Air Canada (AC:CA) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript

Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade

It would be hard for investors to replicate the company's return over the past decade.

Aventus Capital Inc. (AVTS:CA) The Westaim Corporation - Analyst/Investor Day - Slideshow

Abaxx Technologies Is Smashing Volume Records - So I Am Still Not Interested

AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.

AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot

<![CDATA[Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]>

Brookfield Business Corporation (BBUC:CA) Analyst/Investor Day Transcript

Abbott launches ready-to-feed whole milk infant formula

Olema: Best Breast Cancer Therapy, Or SERD Also-Ran? We'll Find Out In Q1 '27

ABM Industries Q3 2026 Earnings Preview

Corby Spirit and Wine Limited (CSW.A:CA) Q4 2026 Earnings Call Transcript

Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?

Abbott trades at a 18x forward P/E with $7.4B in free cash flow, while Intuitive Surgical commands a 39x multiple backed by zero debt and 20% revenue growth.

Brookfield Corporation (BN:CA) Analyst/Investor Day - Slideshow

Dividend Announcements: October 3-9, 2026

AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?

Eli Lilly's metabolic therapies drove 45% revenue growth, but its valuation premium demands scrutiny against AbbVie's defensive dividend appeal.